Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Sonrotoclax plus Zanubrutinib versus placebo plus Zanubrutinib in adults with relapsed/refractory mantle cell lymphoma; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Sonrotoclax
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Mantle Cell Lymphoma, B Cell Lymphoma | Phase 3 | Status: RECRUITING